Canan KABACA, Esra İZMİT OZBASLI, Ateş KARATEKE

ileri Evre EpitelyalOver Kanserinde Lenf N odu Diseksiyonunun Sagkabma Etkisi

Amaf: ileri evre over kanserinde pelvik ve paraaortik lenf nodu diseksiyonunun sagkalzma etkisi ve yo/ at;abilecegi olasz morbiditeler gozoniine almarak primer cerrahi yakla~zmdaki yerinin belirlenmesi Materyal ve Metod: Ocak 2000- Subat 2008 tarihleri arasmda Zeynep Kamil Kadm ve (:ocuk Hastahklarz Egitim ve Ara~tzrma Hastanesi Jinekolojik Onkoloji servisinde ameliyat edilmi~ olan 182 hastamn dosyasz retrospektif olarak incelendi. ileri evre over kanseri (evre IIIC ve evre IV) olan 31 hasta t;alz~maya dahil edildi. Cerrahi prosediirler, klinikopatolojik bulgular, gene/ ve hastalzkszz donem sagkalzm siireleri ara~tzrzldz. As it varlzgz, pozitif sitoloji, rezidiiel tumor varlzgz, histolojik tip, tiimoriin grade ve evresi bu parametrelerin sagkalzm iizerinde herhangi bir etkisinin olup olmadzgzm ara~tzrmak it;in degerlendirildi. Sonut;lar, anlamlzhk pO. 05). Lenf nodu diseksiyonu yapzlan ve yapzlmayan gruplarm gene/ ve hastalzkszz donem sagkalzm siireleri arasmda istatiksel farklzlzk gozlenmemi~tir (p>0.05). Seroz epitelyal over kanseri olgularmda gene/ sagkalzmm diger epitelyal over kanseri subtiplerine gore istatistiksel olarak anlamlz derecede yiiksek bulunmu~tur (p

The effect of lymph node dissection on survival inadvanced stage epithelial ovarian cancer

Objective: To define the effect of the lymph node dissection on survival in advanced ovarian cancer and the place of the procedure in the primary surgical procedure. Materials and Methods: A total of 182 patients with epithelial ovarian carcinoma diagnosed and treated at Zeynep Kamil Hospital during January 2000- February 2008 were retrospectively reviewed Thirty-one patients with advanced stage ovarian carcinoma (stage 3C and stage 4) were included in the study. Surgical procedures, clinicopathological findings, overall and disease free survival periods of the patients, some parameters (ascites, positive cytology, residual tumor, hystology, grade, stage) which might have some effect on survival were evaluated Statistical analysis was performed with independent t and chi-square tests. Differences were considered statistically significant at a probability value of <0.05. The Kaplan-Meier test was used to estimate the survival and log rank test was used to estimate the factors affecting survival. Results: There was no significant difference between the groups with and without lymph node dissection with respect to the median operation time, rate of intraoperative blood transfusion, amount of intraoperative bleeding, complication rates, postoperative stay in hospital, recurrences and deaths (p>O. 05). No significant difference was observed in overall and disease free survival between groups (p>0.05). The overall survival of the serous epithelial ovarian cancer was significantly higher than the non-serous epithelial ovarian cancer (p=0.002). Conclusion: Until definitive data exist, it does not seem logical to inflict the potential morbidity of a lymph node dissection on a patient with palpably normal retroperitoneal nodes in an attempt to by chance detect microscopic tumor deposits.

PDF

___

1. Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocuore E (1993) Assesment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2- [18F] deoxyglucose (2-[18F]FDG). Gynecol Oneal 51:197-204
2. Maiman M (1995) Laparoscopic removal of the adnexal mass: the case for caution. Clin Obstet Gyneco/38:370-379
3. Osmers R (1996) Sonographic evaluation of ovarian masses and its therapeutical implications. Ultrasound Obstet Gynecol 8:217-222
4. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era; a meta-analysis. J Clin Oneal 20: 1248- 1259
5. Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Onco/40: 103-106
6. Di Re F, Baiocchi G, Fontanelli R, Grosso G, Cobellis L, Raspagliesi F, diRe E (1996) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance ofnode metastases. Gynecol Onco/62: 360-365
7. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E (199 5) Systematic pelvic and paraaortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oneal 56: 328-337
8. FIGO Cancer Committee (1986) Staging announcement. Gynecol Oneal 25:383-385
9. Chen SS (1987) Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol Onco/27: 368-372
10. Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, Pomel C, Lhomme C, Duvillard P, Castaigne D (2003) Lymph node CiLT: 42 YIL: 2011 SAYI: I involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. JAm Col! Surg 197:198- 205
11. Kolbenstvedt A, Kolstad P (1976) The difficulties of complete pelvic lymph node dissection in radical hysterectomy for carcinoma of the cervix. Gynecol Onco/4:244-258
12. Kolbenstvedt A, Kolstad P (197 4) Pelvic lymph node dissection under peroperative lymphographic control. Gynecol Onco/2:39-59
13. Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM (2007) Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecologic Oncology 105: 604-608
14. Ferraris G, Lanza A,D 'Addato F, Valli M, Re A, Bellino R, Gordini G, Allone T, Raspollini M (1988) Techniques of pelvic and para-aortic lymphadenectomy in the surgical treatment of cervix carcinoma. Eur J Gynaecol Oneal 9:83-86
15. Angioli R, Plotti F, Palaia I, Calcagno M, Montera R, Cafa EV, Sereni MI, Panici PB (2008) Update on lymphadenectomy in early and advanced ovarian cancer. Curr Opin Obstet Gyneco/20:34-39
16. Spirtos NM, Gross GM, Freddo JL, Bailon SC (1995) Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oneal 56: 345-352
17. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Nat! Cancer Inst 97:560-566
18. Hacker NF (1995) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer-therapeutic advance or surgical folly? Gynecol Oneal 56:325-327
19. Allen D, Planner R8, Grant PT (1992) Maximum effort in the management of ovarian cancer, including pelvic and paraaortic lymphadenectomy. Aust N Z J Obstet Gynaecol 32:50-53.
20. Maggioni A, Benedetti Panici P, Dell 'Anna T, Landoni F, Lissoni A, Pellegrino A, Rossi RS, Chiari S, Campagnutta E, Greggi S, Angioli R, Manci N, Calcagno M, Scambia G, Fossati R, Floriani I, Torri V, Grassi R, Mangioni C (2006) Randomized study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95:699-704
21. Eisenkop SM, Spirtos NM, Montag rw, Nalick RH, Wang HJ (1992) The impact ofsubspeciality training on the management of advanced ovarian cancer. Gynecol Oncol 47: 203-209
22. Bridges JE, Leung Y, Hammond IG, McCartney AJ (199 3) En bloc resection of epithelial ovarian tumors with concomitant rectosigmoid colectomy: the KEMH experience. Int J Gynecol Cancer 3: 199-202
23. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K (2007) The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer 96: 1817-1822
24. Aletti GD, Dowdy S, Podratz KC, Cliby WA (2006) Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. A m J Obstet Gynecol195:1862- 1868
25. Friedlander ML (1998) Prognostic factors in ovarian cancer. Semin Oncol 25:305-315
26. Chi DS, Liao JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ (2001) Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 82:532-537
27. Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma? Gynecol Oncoll03: 559-564